Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 27,865 | 8,979 | 41,955 | 17,085 | 6,227 |
| Depreciation Amortization | 38,780 | 19,131 | 79,322 | 60,128 | 40,987 |
| Income taxes - deferred | 15,998 | 3,463 | 15,615 | 9,014 | 4,100 |
| Accounts receivable | 776 | 3,917 | -7,159 | 1,440 | -683 |
| Accounts payable and accrued liabilities | 2,772 | -6,976 | 916 | 1,988 | 9,683 |
| Other Working Capital | 1,428 | 4,304 | -45,777 | -33,978 | -28,569 |
| Other Operating Activity | 14,718 | 16,283 | 69,777 | 51,388 | 30,882 |
| Operating Cash Flow | $102,337 | $49,101 | $154,649 | $107,065 | $62,627 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -6,758 | N/A | N/A |
| PPE Investments | -4,426 | -2,836 | -15,161 | -13,363 | -9,969 |
| Purchase Of Investment | -105,781 | -56,055 | -137,608 | -118,440 | -76,267 |
| Sale Of Investment | 79,462 | 43,361 | 237,068 | 200,970 | 159,745 |
| Investing Cash Flow | $-30,745 | $-15,530 | $77,541 | $69,167 | $73,509 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 287,500 | N/A | 149,550 | 149,550 | 149,550 |
| Debt Repayment | -205,260 | -2,813 | -330,312 | -327,500 | -299,688 |
| Common Stock Issued | 1,364 | N/A | 4,750 | 3,611 | 3,586 |
| Common Stock Repurchased | -25,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -36,441 | -4 | -7,019 | -6,913 | -6,913 |
| Financing Cash Flow | $22,163 | $-2,817 | $-183,031 | $-181,252 | $-153,465 |
| Beginning Cash Position | 153,298 | 153,298 | 104,139 | 104,139 | 104,139 |
| End Cash Position | 247,053 | 184,052 | 153,298 | 99,119 | 86,810 |
| Net Cash Flow | $93,755 | $30,754 | $49,159 | $-5,020 | $-17,329 |
| Free Cash Flow | |||||
| Operating Cash Flow | 102,337 | 49,101 | 154,649 | 107,065 | 62,627 |
| Capital Expenditure | -4,426 | -2,836 | -15,161 | -13,363 | -9,969 |
| Free Cash Flow | 97,911 | 46,265 | 139,488 | 93,702 | 52,658 |